Journey Medical Profit Margin

The latest profit margin for DERM is -14.82% as of March 2026. That compares with -14.76% in the prior-year period — down 0.4% year over year. That is below the sector sector average of 19.69%. Investors often review this figure alongside Journey Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, DERM's profit margin moved from -14.76% to -14.82% — a 0.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Journey Medical's valuation or profitability profile.

Against its sector companies, DERM currently prints -14.82% for profit margin, while the sector average sits near 19.69%. That is roughly 175.3% below the sector mean. Large gaps often invite a closer look at Journey Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Journey Medical converts resources into returns. At -14.82%, DERM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -14.76% in the prior-year period — down 0.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DERM's profit margin (-14.82%), review year-over-year change from -14.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.